The inappropriate expression of DUX4, followed by the activation of its target genes in the skeletal muscle of FSHD patients, represent crucial events likely driving muscle degeneration in FSHD. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.